PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT

Xiaoqi Wang1, Guangyuan Li1,2, Sanjay Koul1

  • 1Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.

Oncotarget
|June 5, 2018
PubMed

Insights

Pleckstrin homology-like domain family A member 2 (PHLDA2) suppresses lung cancer growth by inhibiting AKT pathway activation, acting as a biomarker for this signaling cascade. PHLDA2 is induced by oncogenic EGFR/ErbB2 signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Pleckstrin homology-like domain family A member 2 (PHLDA2) is a tumor suppressor gene. Its expression is reduced in various cancers.
  • Epidermal Growth Factor Receptor (EGFR) and ErbB2 signaling pathways are frequently dysregulated in cancers, driving tumor growth.
  • The AKT pathway is a critical mediator of cell survival and proliferation in cancer.

Purpose of the Study:

  • To investigate the role of PHLDA2 in lung cancer.
  • To determine the relationship between PHLDA2, EGFR/ErbB2 signaling, and AKT activation.
  • To explore PHLDA2 as a potential biomarker for AKT pathway activation in lung cancer.

Main Methods:

  • Immunohistochemical analysis of PHLDA2 and AKT activation in human lung cancer tissues.
  • In vitro studies to assess the effects of PHLDA2 overexpression and knockdown on AKT phosphorylation and activity.
  • Cellular assays to evaluate PHLDA2's impact on anchorage-independent growth, proliferation, and sensitivity to targeted therapies.

Main Results:

  • PHLDA2 expression positively correlates with AKT activation in lung cancers.
  • PHLDA2 overexpression inhibits AKT phosphorylation and membrane translocation, while PHLDA2 knockdown enhances AKT activity.
  • PHLDA2 overexpression suppresses anchorage-independent growth, and its decreased expression increases proliferation and reduces sensitivity to EGFR/ErbB2-targeted agents.

Conclusions:

  • PHLDA2 is a downstream target of oncogenic EGFR/ErbB2 signaling and negatively regulates AKT activation in lung cancer.
  • PHLDA2 acts as a direct inhibitor of AKT by competing for membrane lipid binding, thus repressing cell proliferation.
  • PHLDA2 serves as a potential biomarker for AKT pathway activation and a therapeutic target in EGFR/ErbB2-driven lung cancers.

Related Concept Videos

Cell Signaling Feedback Loops01:07

Cell Signaling Feedback Loops

Positive and negative feedback loops are crucial for regulating biological signaling systems. These feedback loops are processes that connect output signals to their inputs.
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
7.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.6K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
40.9K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
131.0K
Positive and Negative Feedback Loops01:18

Positive and Negative Feedback Loops

Animal organs and organ systems constantly adjust to internal and external changes through a process called homeostasis ("steady state"). Examples of these changes include regulation of the level of glucose or calcium in the blood or internal responses to external temperatures. Homeostasis requires  maintaining an internal dynamic equilibrium:
25.4K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.2K